golden ally lifetech group inc - AQPW

AQPW

Close Chg Chg %
0.00 0.00 0.00%

Closed Market

0.00

0.00 (0.00%)

Volume: 1.50K

Last Updated:

Dec 2, 2025, 12:21 PM EDT

Company Overview: golden ally lifetech group inc - AQPW

AQPW Key Data

Open

$0.00

Day Range

0.00 - 0.00

52 Week Range

0.00 - 0.00

Market Cap

$0.00

Shares Outstanding

7.41B

Public Float

260.56M

Beta

1.21

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.00

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.35K

 

AQPW Performance

No Data Available

AQPW Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About golden ally lifetech group inc - AQPW

Golden Ally Lifetech Group, Inc. operates as a developmental stage company. It engages in business activities in the fields of graphene related technologies and applications, energy solutions, and medical devices. The company was founded on February 2, 2005 and is headquartered in Austin TX.

AQPW At a Glance

Golden Ally Lifetech Group, Inc.
901 South Mopac Expressway
Austin, Texas 78746
Phone 1-512-430-1553 Revenue 0.00
Industry Medical Specialties Net Income -6,071,587.00
Sector Health Technology Employees 11
Fiscal Year-end 12 / 2023
View SEC Filings

AQPW Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio N/A
Price to Book Ratio 1,285.71
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -380.016
Enterprise Value to Sales N/A
Total Debt to Enterprise Value 0.00

AQPW Efficiency

Revenue/Employee N/A
Income Per Employee -551,962.455
Receivables Turnover N/A
Total Asset Turnover N/A

AQPW Liquidity

Current Ratio 16.507
Quick Ratio 16.507
Cash Ratio 5.919

AQPW Profitability

Gross Margin N/A
Operating Margin N/A
Pretax Margin N/A
Net Margin N/A
Return on Assets -694.099
Return on Equity -772.007
Return on Total Capital -358.825
Return on Invested Capital -757.084

AQPW Capital Structure

Total Debt to Total Equity 6.32
Total Debt to Total Capital 5.944
Total Debt to Total Assets 5.845
Long-Term Debt to Equity 1.961
Long-Term Debt to Total Capital 1.832
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Golden Ally Lifetech Group Inc - AQPW

Collapse All in section
All values USD millions. 2019 2020 2021 2022 5-year trend
Sales/Revenue
- - - -
-
Sales Growth
- - - -
-
Cost of Goods Sold (COGS) incl D&A
- - - 40.31K
-
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
- - - 40.31K
-
Depreciation
- - - 40.31K
-
Amortization of Intangibles
- - - -
-
COGS Growth
- - - -
-
Gross Income
- - - (40.31K)
-
Gross Income Growth
- - - -
-
Gross Profit Margin
- - - -
-
2019 2020 2021 2022 5-year trend
SG&A Expense
114.03K 354.78K 188.96K 6.03M
Research & Development
- - 1.00K 98.45K
-
Other SG&A
114.03K 354.78K 187.96K 5.93M
SGA Growth
+40.78% +211.14% -46.74% +3,091.81%
Other Operating Expense
- - - -
-
Unusual Expense
- - - -
-
EBIT after Unusual Expense
(114.02K) (354.78K) (188.96K) (6.07M)
Non Operating Income/Expense
- - (720) 14.05K
-
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
(114.75K) (354.78K) (174.91K) (6.07M)
Pretax Income Growth
-41.67% -209.17% +50.70% -3,371.24%
Pretax Margin
- - - -
-
Income Tax
- - - -
-
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(114.75K) (354.78K) (174.91K) (6.07M)
Minority Interest Expense
- - - -
-
Net Income
(114.75K) (354.78K) (174.91K) (6.07M)
Net Income Growth
-41.67% -209.17% +50.70% -3,371.24%
Net Margin Growth
- - - -
-
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(114.75K) (354.78K) (174.91K) (6.07M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(114.75K) (354.78K) (174.91K) (6.07M)
EPS (Basic)
-0.0086 -0.0185 -0.0085 -0.0007
EPS (Basic) Growth
-26.47% -115.12% +54.05% +91.76%
Basic Shares Outstanding
13.39M 19.16M 20.56M 8.49B
EPS (Diluted)
-0.0086 -0.0185 -0.0085 -0.0007
EPS (Diluted) Growth
-26.47% -115.12% +54.05% +91.76%
Diluted Shares Outstanding
13.39M 19.16M 20.56M 8.49B
EBITDA
- (354.78K) (188.96K) (6.03M)
EBITDA Growth
- - +46.74% -3,091.83%
-
EBITDA Margin
- - - -
-

Golden Ally Lifetech Group Inc in the News